Octave Intelligence

OCTV · NASDAQ

$20.49−$0.03 (−0.15%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $20.52

OCTV analyst rating

HoldConsensus of 6 analysts over the last 12 months. 17% rate it a buy.

Strong buy0
Buy1
Hold5
Underperform0
Sell0

12-month price target · 7 analysts

Average $23.77 (+16.0% upside)

Low: $20.20
Now: $20.49
High: $31.50

Upgrades and downgrades

The latest rating actions, newest first

OCTV analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Morgan Stanley	Sep 17, 2026	Initiates	Equal-Weight	$21.00	54%
Barclays	Jun 18, 2026	Initiates	Equal-Weight	$18.00	—
Evercore ISI Group	Jun 12, 2026	Initiates	In-Line	$20.00	59%
RBC Capital	Jun 2, 2026	Initiates	Sector Perform	$21.00	61%
Goldman Sachs	Jun 1, 2026	Initiates	Neutral	$17.00	58%
Guggenheim	May 29, 2026	Initiates	Buy	$30.00	59%

The case for and against

Updated Oct 15, 2026

Bull case

Octave Intelligence is positioned as a durable vertical software compounder because independence should unify management, P&L, and R&D, unlocking revenue synergies, cost synergies, and faster SaaS execution across Design, Build, Operate, and Protect. Its fundamentals support that thesis: ARR rose from $952M in 2023 to $1,117M in 2025, gross retention is 97% and net retention is 105%, while subscription revenue reached 66% of revenue in CY/25 and gross margin improved to 75%. With a $28B SAM in 2025 growing to over $40B by 2029, plus strong cross-sell economics, AI productivity gains, and an expected path toward 10%+ ARR growth and ~30% adjusted operating margin, the stock appears set up for margin expansion and compounding.

Bear case

Octave Intelligence is viewed negatively because it faces a difficult stand-alone transition with no operating history as an independent public company, two disclosed material weaknesses in internal controls, and at least CY/27 of separation-related costs that add to a roughly $7.8M pre-tax management-adjustment drag plus $11.2M of one-time costs. The SaaS shift also creates a noisy near-term profile, with CY/26 organic revenue growth of only 3-4% versus 6-8% ARR growth and adjusted operating margin expected to be flat to slightly down as perpetual licenses roll off and capitalized R&D falls from 8% of revenue toward 4%. Further pressure comes from concentration in the Americas, about 5% exposure to the Middle East, currency exposure on 52% of 2025 revenue, and competitive and integration risks while the base platform and AI roadmap are still being integrated.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.